Total Operating Expenses: Total operating expenses were $42.9 million for the first quarter of 2025, including research and ...

Japan has made regenerative medicine a priority. It was the first country to approve clinical use of iPS cells, and it ...

Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, Academics and Research Institutes, Hospital).

Financially, Creative Medical has limited cash reserves, high cash burn, and will likely need dilutive financing. Click here ...

People with type 2 diabetes don’t make an adequate amount of insulin to manage their blood sugar. Stem cell therapy may ...

A study from Australia shows that exercise improves outcomes of stem cell-derived dopaminergic neuron transplants in rats ...

A new model of tiny human ovary organoids, or ovaroids, has been developed from stem cells, according to research presented ...

In an achievement that was far more complex to achieve than it might sound, researchers now say they have figured out how to make tiny human kidney organoids that generate a criti ...

Parkinson's disease (PD) is a disabling neurodegenerative disease that affects approximately 10 million people worldwide, ...

A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...